Skip to content

Electro-thumbtack Needle Therapy for Chronic Neck Pain

Efficacy and Safety of Electro-thumbtack Needle Therapy for Patients With Chronic Neck Pain: a Randomized, Placebo-controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04981171
Enrollment
180
Registered
2021-07-28
Start date
2022-06-06
Completion date
2025-01-15
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Brief summary

This prospective trial will be a single-center, participant-blinded, randomized controlled trial. It is reported in previous studies that both acupuncture and transcutaneous electrical nerve stimulation are effective in reducing neck pain comparing to placebo or exercise. Taking into account the convenience of electro-thumbtack needle therapy shown in clinical practice, this study aims to evaluate the efficacy and safety of electro-thumbtack needle therapy for alleviating chronic neck pain compared with sham electro-thumbtack needle therapy.

Detailed description

Chronic neck pain is a commonly experienced symptom that often influences work efficiency and life satisfaction for years. A total of 180 participants suffering mechanical chronic neck pain will be recruited and randomized into either electro-thumbtack needle therapy group or sham electro-thumbtack needle therapy group. All participants will receive the standardized neck exercise instruction at their first treatment session and will be asked to perform the exercise once every day during 4-week treatment. All assessments will be performed by the assessor and the assessment results will be all kept from the acupuncturist. The statistician will be involved in neither assessment nor treatment and will be blinded regarding intervention group code.

Interventions

PROCEDUREElectro-thumbtack Needle Therapy

Each treatment session starts with sterilizing acupoints. Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) have been selected in accordance with the principle of acupuncture prescription making and the consensus of experts on treating neck pain. Electro-thumbtack needles (0.25×2 mm) will be held by the acupuncturist between thumb and forefinger, vertically inserted into skin instantly and taped well on skin. Then assemble the gel electrodes to the surface of the conductive adhesive tape, also assemble the portable stimulation devices, adjust the current intensity from level 1 to a proper level that the participant can tolerate. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.

PROCEDURESham electro-thumbtack needle therapy

Each treatment session starts with sterilizing acupoints. Sham electro-thumbtack needles (0.25×0.2 mm) will be held by the acupuncturist between thumb and forefinger, taped well on skin without penetration. The adhesive tape of needles are also produced with conductive material, after assembling the gel electrodes and the portable stimulation devices, adjust the current intensity to level 1 for a minimal stimulus which will last for only 30 seconds. By this time the acupuncturist will turn the device off to cut the current. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.

Sponsors

Shi Hangyu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with neck pain with headaches or neck pain with movement coordination impairments according to the Orthopaedic Section of the American Physical Therapy Association (APTA); 2. Aaged 18-65 years; 3. History of neck pain for at least 3 months; 4. A score of ≥4 in Numerical Rating Scale for neck pain (NRS-NP) assessing the average neck pain intensity over last 7 days until the day of recruitment.

Exclusion criteria

1. Diagnosed with neck pain with mobility deficits or neck pain with radiating pain according to the Orthopaedic Section, APTA; 2. Known specific reason leading to neck pain such as tumor, immune disease, endocrine and metabolic disorders, neurological abnormalities, cervical vertebra fracture, cervical dislocation; 3. Acute neck pain or neck pain with radiating pain or upper limb symptoms; 4. Neck pain with sensory or motor disturbance; 5. Prior cervical spine surgery or congenital abnormalities; 6. Experiencing medical dispute litigation; 7. Have received acupuncture in last 30 days; 8. In need of analgesic, muscle relaxant, hormones, or bearing greater pain from another area; 9. Allergic to metal or adhesive tape, or carrying cardiac pacemaker, or skin damaged at selected acupoints; 10. Disable to communicate or critically ill; 11. Drug or alcohol dependent; 12. Currently or planning to be pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants with an at least 50% decrease in NRS-NP from baseline.week 4Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)

Secondary

MeasureTime frameDescription
Change of NRS-NP from baseline.week 4, 16, 28Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
Proportion of participants with an at least 50% decrease in NRS-NP from baseline.week 16, 28Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
Proportion of participants with an at least 30% decrease in NRS-NP from baseline.week 4, 16, 28Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
Change of NPQ from baseline.week 4, 16, 28NPQ is a validated questionnaire to learn about the quality and the duration of neck pain and the difficulty coping with chores because of the pain. It contains 9 questions, each ranging from 0 to 4. The total score will be converted to NPQ percentage score (divided by 36 for people who drive and by 32 for those who don't), which ranges from 0 to 100%. High scores indicate worse condition.
Proportion of participants with an at least 25% decrease in NPQ from baseline and a "better" or "much better" for global effectiveness rating.week 4, 16, 28NPQ is a validated questionnaire to learn about the quality and the duration of neck pain and the difficulty coping with chores because of the pain. It contains 9 questions, each ranging from 0 to 4. The total score will be converted to NPQ percentage score (divided by 36 for people who drive and by 32 for those who don't), which ranges from 0 to 100%. High scores indicate worse condition.
Change of NDI from baseline.week 4, 16, 28NDI is a widely used instrument to measure self-reporting disability due to neck pain. It consists of 10 items scored with an ordinal scale from 0-5. The total score ranges from 0-50. Higher scores indicate greater functional limitation. The translated simplified-Chinese version of NDI has been shown to be a responsive and valid measurement for simplified-Chinese speaking patients.
Proportion of participants with an at least 10-point decrease in NDI from baseline.week 4, 16, 28NDI is a widely used instrument to measure self-reporting disability due to neck pain. It consists of 10 items scored with an ordinal scale from 0-5. The total score ranges from 0-50. Higher scores indicate greater functional limitation. The translated simplified-Chinese version of NDI has been shown to be a responsive and valid measurement for simplified-Chinese speaking patients.
Degree of PGIC.week 4, 28Characterize the participants' overall satisfaction and personal feelings about treatment delivery. The options are ranking from "very much worse" to "very much improved" for patients to define their overall status compared with the start of the study.

Countries

China

Contacts

PRINCIPAL_INVESTIGATORHangyu Shi

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026